Rybka WB - Search Results

1

T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients.

Kong Y, Zhu L, Schell TD, Zhang J, Claxton DF, Ehmann WC, Rybka WB, George MR, Zeng H, Zheng H. Kong Y, et al. Among authors: rybka wb. Clin Cancer Res. 2016 Jun 15;22(12):3057-66. doi: 10.1158/1078-0432.CCR-15-2626. Epub 2016 Jan 13. Clin Cancer Res. 2016. PMID: 26763253

2

PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation.

Kong Y, Zhang J, Claxton DF, Ehmann WC, Rybka WB, Zhu L, Zeng H, Schell TD, Zheng H. Kong Y, et al. Among authors: rybka wb. Blood Cancer J. 2015 Jul 31;5(7):e330. doi: 10.1038/bcj.2015.58. Blood Cancer J. 2015. PMID: 26230954 Free PMC article.

3

Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia.

Zhu L, Kong Y, Zhang J, Claxton DF, Ehmann WC, Rybka WB, Palmisiano ND, Wang M, Jia B, Bayerl M, Schell TD, Hohl RJ, Zeng H, Zheng H. Zhu L, et al. Among authors: rybka wb. J Hematol Oncol. 2017 Jun 19;10(1):124. doi: 10.1186/s13045-017-0486-z. J Hematol Oncol. 2017. PMID: 28629373 Free PMC article.

4

Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients.

Jia B, Wang L, Claxton DF, Ehmann WC, Rybka WB, Mineishi S, Rizvi S, Shike H, Bayerl M, Schell TD, Hohl RJ, Zheng H. Jia B, et al. Among authors: rybka wb. Blood Cancer J. 2018 Mar 21;8(3):34. doi: 10.1038/s41408-018-0069-4. Blood Cancer J. 2018. PMID: 29563517 Free PMC article. No abstract available.

5

Eomes⁺T-bet^low CD8⁺ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia.

Jia B, Zhao C, Rakszawski KL, Claxton DF, Ehmann WC, Rybka WB, Mineishi S, Wang M, Shike H, Bayerl MG, Sivik JM, Schell TD, Drabick JJ, Hohl RJ, Zheng H. Jia B, et al. Among authors: rybka wb. Cancer Res. 2019 Apr 1;79(7):1635-1645. doi: 10.1158/0008-5472.CAN-18-3107. Epub 2019 Feb 1. Cancer Res. 2019. PMID: 30709927

6

Multi-dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML.

Zhao C, Jia B, Wang M, Schell TD, Claxton DF, Ehmann WC, Rybka WB, Mineishi S, Naik S, Songdej N, Sivik JM, Hohl RJ, Zeng H, Zheng H. Zhao C, et al. Among authors: rybka wb. Br J Haematol. 2020 Mar;188(5):674-684. doi: 10.1111/bjh.16228. Epub 2019 Oct 1. Br J Haematol. 2020. PMID: 31573077 Free PMC article. Clinical Trial.

7

Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation.

Claxton DF, Ehmann C, Rybka W. Claxton DF, et al. Br J Haematol. 2005 Jul;130(2):256-64. doi: 10.1111/j.1365-2141.2005.05600.x. Br J Haematol. 2005. PMID: 16029454 Free article.

8

Phase I/II study of clofarabine, etoposide, and mitoxantrone in patients with refractory or relapsed acute leukemia.

Abbi KK, Rybka W, Ehmann WC, Claxton DF. Abbi KK, et al. Clin Lymphoma Myeloma Leuk. 2015 Jan;15(1):41-6. doi: 10.1016/j.clml.2014.06.005. Epub 2014 Jun 11. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25085441 Clinical Trial.

9

Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion.

Shah N, Rakszawski K, Nickolich M, Ehmann C, Wirk B, Naik S, Rybka W, Zheng H, Mierski J, Silar B, Mackey G, Greiner R, Brown V, Claxton D, Mineishi S, Minagawa K. Shah N, et al. Ann Hematol. 2021 Oct;100(10):2585-2592. doi: 10.1007/s00277-021-04616-7. Epub 2021 Jul 29. Ann Hematol. 2021. PMID: 34322774

10

VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML.

Wang L, Jia B, Claxton DF, Ehmann WC, Rybka WB, Mineishi S, Naik S, Khawaja MR, Sivik J, Han J, Hohl RJ, Zheng H. Wang L, et al. Among authors: rybka wb. Oncoimmunology. 2018 Jul 11;7(9):e1469594. doi: 10.1080/2162402X.2018.1469594. eCollection 2018. Oncoimmunology. 2018. PMID: 30228937 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters